"Cardiomagnyl": megide-egosi nke ahụ, iji

Drug "Cardiomagnyl" na-ezo aka a ìgwè nke pharmacological mmadụ na a siri ike antiplatelet mmetụta. O nwere acetylsalicylic acid ka onye nọ n'ọrụ akụrụngwa. Nke a ihe onwunwe na-eji na-adakarị omume ruo ihe karịrị 130 afọ na abụrụwo ya irè. Na-abawanye na ọnụ ọgụgụ nke gbasara obi na vaskụla pathologies n'ozuzu morbidity na enwe mba òtù Cardiology (European Cardiology obodo na ndị ọzọ mgbanwe American Heart Association) nwere ike ikwu na ojiji nke kardioform acetylsalicylic acid dị ka ihe irè mgbochi ọgwụ.

Mkpa nke ha na ngwa n'ihi ịrịba ọnụ na ọnụ ọgụgụ nke myocardial infarction na ụbụrụ na ọnụnọ nke atherosclerotic ọnya nke ọbara arịa. N'otu aka ahụ ziri ezi ngwa "cardiomagnyl" ụkwụ na varicose veins. Nke a na-ebelata likelihood nke thrombosis akpa ume akwara alaka pelvis. Ya mere, ọ bụla nke kardioform aspirin nwere a ọtụtụ ihe ndị ọzọ mma akụkụ nke ngwa, kama mmetụta.

usoro nkọwa

Na nkwadebe "Cardiomagnyl" ntuziaka maka ojiji depụtara contraindications ọtụtụ ihe-nkọwa dị ka o kwere. Ọ bụ oge a na na elu-àgwà ọgwụ dị mkpa n'ezie na-adakarị omume. Ọ bụ dị na a price na a ga-etinyere anọgide, ma ọ bụrụ na ọ na-enye ohere onye ọrịa ahụ ike.

Dị ka nọ n'ọrụ umi acetylsalicylic acid na-eji. Strong antiplatelet mmetụta, na-egbochi platelet adhesion na thrombus guzobere top, bụ ihe dị mkpa ngwá ọrụ na mgbochi nke nnukwu akwara ihe. Na nke a nkwadebe "Cardiomagnyl" contraindications ruru ka ngwa nke ihe enteric film mkpuchi na cytoprotector gbanwere n'ụzọ n'ala tụnyere na mbụ, zheludochnorastvorimymi kardioformami ASA.

egosi

Na nkwadebe "Cardiomagnyl" contraindications ruru enteric ụdị obere ịrịba ama, ọ bụ ezie na ego nke na-agụ na-adịghị emetụta. Ọ, dị ka zheludochnorastvorimye kardioformy, eji na-esonụ na-adakarị ọnọdụ:

• n'oge nnukwu myocardial infarction ke nzọụkwụ ST nke elu cardiographic na-enweghị ya;
• na -ejighị n'aka rịaworo ka nnukwu na-elekọta na ogologo okwu ọgwụgwọ;
• na ischemic ọrịa strok na nnukwu na ụdi oge, nakwa dị ka ogologo oge ọgwụ;
• na-akwụsị akwụsị ischemic ọgụ n'ihi na ogologo oge ọgwụgwọ;
• na mgbochi nke myocardial infarction, mgbe onye ọrịa ahụ na-echegbu-aga n'ihu rịaworo;
• na mgbochi nke ischemic ọrịa strok na ndabere omume nke na-akwụsị akwụsị ischemic agha;
• venous varicose ọrịa nke pelvis ma na ala na nsọtụ;
• na mgbochi nke thrombosis nke shunts mgbe CABG (UGS), BPD;
• na ọnụnọ nke ọbara mgbali na ọrịa na-ama elu obi n'ihe ize ndụ.

Ikpeazụ kọrọ na-achọ nhọpụta nke "Cardiomagnyl" ọgwụ ọjọọ na contraindications bụ dị ka mkpa dị ka ọgwụgwọ mmetụta. Ebe ọ bụ na ihe ọ bụla nke na-adakarị ọnọdụ a kọwara n'elu ọgwụ nwere ihe bara uru karịa a nwere ma ọ bụ n'ezie mmebi, ọ na-ghọtara na-aka mma na ọ na-atụ aro na ọnụnọ nke ihe ize ndụ nke ọrịa ụbụrụ infarction, infarction ma ọ bụ thrombosis na akpa ume akwara emebiwo arịa.

contraindications

N'agbanyeghị nke ọnụnọ enteric-aga n'ihu ụdị ọgwụ "Cardiomagnyl" contraindications ọgwụ bụ ka dị. Ha na-ekpuchi ọnọdụ nke ojiji nke acetylsalicylic acid nsogbu karịa ndị bara uru iji. Na ndị a na-adakarị ọnọdụ, "Cardiomagnyl" nwere ike dochie anya ihe analogue nke klas - pụtara "clopidogrel". Contraindications na-agụnye:

• a ọbara ọgbụgba aghara (hemophilia, hemorrhagic diathesis, thrombocytopenia);
• organic ọrịa nke afo (erosions, nnukwu ọnyá 12 duodenal ọnyá afọ, nnukwu gastric ọnyá, ọ bụla na-agba ọbara si eriri afọ tract);
• ime na mbụ na nke atọ trimesters;
• ala nke lactation;
• oké hepatic odida na a creatinine nwechapụ erughị 30 ml / min.;
• gbasara akụrụ odida (a ikpe na-kpebisiri ike n'otu n'otu n'ihi na "Cardiomagnyl" nkwadebe na-egosi na contraindications);
• Anabata ọ bụla salitsillaty;
• bronchial ụkwara ume ọkụ mgbe ọ bụla na-adakarị ogbo na n'ókè nke mgbaàmà;
• Methotrexate;
• afọ 18 afọ.

Mmetụta na mkpa ikpokọta

Kwesịrị ịdị, na fọrọ nke nta ka ọ bụla ọgwụ nwere ma ọgwụgwọ na mmetụta. Otu e ji mara na-akwanyere ndị owuwu na "Cardiomagnyl". Contraindications, mmetụta na na atụmatụ nke ya ngwa kwesịrị ịbụ bụrụkwa ibiere maka oru nke ọgwụ na onye ọrịa. Ndị kasị sie ike na-ezighị ezi mmetụta bụ mebiri nke ozuzu nke gastric na nsia epithelial mkpụrụ ndụ na n'ihe ize ndụ nke ozize na mmerụ ahụ nke mucous membranes, sochiri agba ọbara site elu eriri afọ tract.

The puru nke mmebi nke afo na eriri afọ na-ụba mgbe na ojiji nke ọgwụ ọjọọ, "Methotrexate" na ndị ọzọ cytostatics. All NSAIDs dịkwuo mmetụta nke ọgwụ n'okpuru echiche na-atụ aro maka-ekere òkè na ya ngwa.

Drug "Cardiomagnyl", na ojiji nke na contraindications nke ibe, ike exacerbate mebiri imeju ọrụ, ma ọ bụrụ na onye ọrịa n'oge ọgwụgwọ nke na-aṅụ mmanya. Ọ dịkwa ike na-asọ salicylates. Common mmetụta bụ bronchospasm, mụbara agba ọbara, isi ọwụwa, na ehighị ụra nke ọma. Na-adịghị ahụkebe pụta ìhè nwere ike na-akpọ tinnitus, dizziness, iro ụra. The puru ọgwụ nsi bụ naanị na ikpe nke a otu oge oriri nke 60 ma ọ bụ karịa mbadamba 75 mg.

onunu ogwu ụdị

Nkwadebe "Cardiomagnyl" (contraindications na mmetụta tụlere n'elu) na-akọ na a n'oge a conventionally mma ọgwụ n'ihi ọnụnọ enteric mkpuchi. Ọ bụ ugbu a na ọtụtụ ndị ọzọ yiri ọgwụ, ebe ọ bụ na a ghọtara ọkọlọtọ pharmacological onunu ogwu ụdị ike ike kwupụta afo. Ngwá Ọrụ dị na mbadamba, mere ke udi nke a obi.

The mejupụtara na onunu ogwu

The ọgwụ dị na abụọ ọkọlọtọ Dosages nke 75 na 150 mg. Ha na-ahọpụta dị ka anabata dose na-adakarị ọnọdụ. Ọtụtụ mgbe eji na dose of 75 mg. Ọ na-atụ aro maka otu ochichi ke nri abalị dika egosi kọwara n'elu.

A mbadamba gụnyere 75 mg acetylsalicylic acid, magnesium hydroxide - 15.2 mg. Ọzọkwa, ha nọ na ihe ndị mejupụtara nke excipients: magnesium stearate - 150 mcg Microcrystalline cellulose - 12.5 mg ọka starch - 9.5 mg nduku starch - 2.0 mg.

All mkpa isi banyere ọgwụ "Cardiomagnyl" (contraindications, oge nke n'ikuku, njirimara nke oghom mmetụta na akara) ga-kpọtụụrụ dọkịta gị. Nzube nke akara nke dose na ọgwụgwọ a a cardiologist ma ọ bụ internist.

Nyocha ọkachamara banyere ọgwụ

Ọ dị mkpa ezipụta na collection of mgbakọ na mwepụ data akwado ò kwesịrị ekwesị ọgwụ. Ya mere niile kardioformy, gụnyere zheludochnorastvorimye, a 16% ala enwe ọnụego n'etiti ọrịa na-ama elu obi n'ihe ize ndụ. Ịṅụ Ọgwụ Aspirin ebelata likelihood nke a nkeji iri na ise nke a akpa ume embolism na ọbara ischemic ọrịa strok.

Ọzọkwa, "Cardiomagnyl" by 29% na-ebelata ihe ize ndụ nke clinically ịrịba pelvic akwara thrombosis nke ala ụkwụ na ọnụnọ nke varicose. Ihe kasị mkpa bụ pụtara iji belata likelihood nke myocardial infarction na ọnụnọ nke ọ bụla n'ụdị nke-adịghị ala ala gbasara obi ischemia. All ndị a na mmetụta ikpokọta dịkwuo ndu ndimmadu nke ọ bụla ndidi na-enwe a n'ihe ize ndụ nke ọrịa ụbụrụ infarction na n'obi. Ọzọkwa, 40% of acetylsalicylic acid kardioformy belata likelihood nke thrombosis nke shunts maka ihe ọ bụla revascularization n'ịwa ahụ.

City feature echiche nke ọrịa

Nleba banyere ọgwụ na-abụkarị ndị na-indicative, n'ihi na e nweghị ngwa ngwa iji chọpụta irè nke ọgwụ. Ya mere, a onye na-họpụtara "Cardiomagnyl" ga-dabere na a dọkịta nkwanye. Nke a conventionally mma ọgwụ na kwesịrị ekwesị ngwa nke nke mmetụta na-ebelata. Otú ọ dị, pooled analysis of ndidi ahụmahụ na-egosi na "Cardiomagnyl" ka mma jiworo kwe ka ọ bụla zheludochnorastvorimyh kardioform.

Atụmatụ nke ngwa

Ịtụle ihe e ji mara "Cardiomagnyl" reviews, contraindications, obosara nke ọgwụgwọ edinam, dọkịta ga nwere ike ikwu na onunu ogwu maka ọgwụgwọ. N'ọnọdụ ka ukwuu, dị ka na-atụ aro AHA na ESC 2014 2014 etinyere dose of 75 mg. 150 mg nke acetylsalicylic acid na-atụ aro maka ọrịa na-elu ibu ma saa mbara (akp stenoses) nke akwara akwara.

The ọgwụ ga-na etinyere anọgide na, ọ bụrụ na otú rịọrọ site adakarị ọnọdụ, a ga-nwayọọ nwayọọ na-kagburu n'ihi likelihood nke nnukwu thrombosis ke akpa ụbọchị iri nke ndị jụrụ nke mbanye. Dị ka ihe ọtụtụ nnyocha nke pharmacokinetics na pharmacodynamics nke acid, ọ na-atụle ihe ndị kasị ala n'ikuku mgbe nri abalị maka 1.5 awa tupu alakpu ụra.